Vandenplas Yvan, Ludwig Thomas, Bouritius Hetty, Alliet Philippe, Forde Derek, Peeters Stefaan, Huet Frederic, Hourihane Jonathan
Department of Pediatrics, UZ, Vrije Universiteit Brussel, Brussels, Belgium.
Nutricia Research, Utrecht, The Netherlands.
Acta Paediatr. 2017 Jul;106(7):1150-1158. doi: 10.1111/apa.13844. Epub 2017 Apr 19.
We examined the effects on gastrointestinal (GI) tolerance of a novel infant formula that combined specific fermented formula (FERM) with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides (scGOS/lcFOS), with a 9:1 ratio and concentration of 0.8 g/100 mL.
This prospective, double-blind, randomised, controlled trial comprised 432 healthy, term infants aged 0-28 days whose parents decided to not start, or discontinued, breastfeeding. Infant formula with scGOS/lcFOS+50%FERM, scGOS/lcFOS+15%FERM, 50%FERM and scGOS/lcFOS were tested. Parents completed standardised seven-day diaries on GI symptoms, crying, sleeping and stool characteristics each month until the infants were 17 weeks.
All the formulas were well tolerated. At four weeks, the overall incidence of infantile colic was significantly lower (8%) with scGOS/lcFOS+50%FERM than scGOS/lcFOS (20%, p = 0.034) or 50%FERM (20%, p = 0.036). Longitudinal modelling showed that scGOS/lcFOS+50%FERM-fed infants also displayed a persistently lower daily crying duration and showed a consistent stool-softening effect than infants who received formula without scGOS/lcFOS.
The combination of fermented formula with scGOS/lcFOS was well tolerated and showed a lower overall crying time, a lower incidence of infantile colic and a stool-softening effect in healthy term infants. These findings suggest for the first time that a specific infant formula has a preventive effect on infantile colic in formula-fed infants.
我们研究了一种新型婴儿配方奶粉对胃肠道(GI)耐受性的影响,该配方奶粉将特定的发酵配方(FERM)与短链低聚半乳糖和长链低聚果糖(scGOS/lcFOS)以9:1的比例、0.8 g/100 mL的浓度混合。
这项前瞻性、双盲、随机对照试验纳入了432名0至28天的健康足月儿,其父母决定不开始或已停止母乳喂养。对含有scGOS/lcFOS+50%FERM、scGOS/lcFOS+15%FERM、50%FERM和scGOS/lcFOS的婴儿配方奶粉进行了测试。父母每月填写关于胃肠道症状、哭闹、睡眠和粪便特征的标准化七天日记,直至婴儿17周龄。
所有配方奶粉的耐受性都很好。在四周时,scGOS/lcFOS+50%FERM组婴儿肠绞痛的总体发生率(8%)显著低于scGOS/lcFOS组(20%,p = 0.034)或50%FERM组(20%,p = 0.036)。纵向模型显示,与接受不含scGOS/lcFOS配方奶粉的婴儿相比,喂养scGOS/lcFOS+50%FERM的婴儿每日哭闹持续时间也持续较低,并且显示出持续的粪便软化效果。
发酵配方与scGOS/lcFOS的组合耐受性良好,在健康足月儿中显示出总体哭闹时间更短、婴儿肠绞痛发生率更低和粪便软化效果。这些发现首次表明,一种特定的婴儿配方奶粉对配方奶喂养婴儿的婴儿肠绞痛具有预防作用。